Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment
- Inhaled corticosteroids and risk of cataract formation. Kirchner, Jeffrey T. // American Family Physician;12/1/1997, Vol. 56 Issue 9, p2333
Presents the summary of the article `Use of Inhaled Corticosteroids and the Risk of Cataracts,' by R.G. Cumming from the `Northern England Journal of Medicine' dated 1997. Effects of inhaled corticosteroids; Cumulative lifetime dosage of beclomethasone.
- Autoimmune pancreatitis in Japan: overview and perspective. Shimosegawa, Tooru; Kanno, Atsushi // Journal of Gastroenterology;2009, Vol. 44 Issue 6, p503
Since the rediscovery and definition of autoimmune pancreatitis (AIP) by Yoshida et al. in 1995, the disease has been attracting attention because of its unique clinical features and practical issues. This disease shows very impressive imaging findings, serological changes, and characteristic...
- a closer look at corticosteroids. DUNKIN, MARY ANNE // Arthritis Today;Jul/Aug2012, Vol. 26 Issue 4, p54
The article discusses corticosteroids, which are used to treat inflammatory forms of arthritis, including rheumatoid arthritis, lupus and ankylosing spondylitis. The various forms and uses of corticosteroids are listed, including oral, intravenous and ocular. Solutions to common side effects of...
- Corticosteroid Therapy for Chronic Active Hepatitis. Berk, Paul D.; Jones, E. Anthony // Annals of Internal Medicine;Oct76, Vol. 85 Issue 4, p523
Editorial. Offers observation on published reports of studies on the use of corticosteroid for the treatment of chronic active hepatitis. Brief background on the term chronic active hepatitis; Views on the therapy; Effect of remission.
- Low-dose oral steroids yielded similar outcomes as higher-dose IV steroids in patients with COPD. // Infectious Disease News;Aug2010, Vol. 23 Issue 8, p21
The article discusses research being done on the effectiveness of oral corticosteroid therapy as intravenous corticosteroid therapy in treating patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease, which references the study by P. K. Lindenauer in the journal...
- American Thoracic Society Intl Conference Long-term ICS use reduces pleural effusion in patients with CAP. // Biomedical Market Newsletter;6/1/2012, Vol. 21, p1
The article focuses on a study according to which prior treatment with inhaled corticosteroids in patients with respiratory disorders who develop community acquired pneumonia (CAP) is associated with a lower incidence and severity of parapneumonic effusion.
- Corticosteroid use and MetS in systemic lupus erythematosis. // Reactions Weekly;9/15/2012, Issue 1419, p2
The article reports on a study which found that corticosteroid and immunosuppressant use are among the risk factors for the metabolic syndrome (MetS) in systemic lupus erythematosus (SLE) patients.
- Are glucocorticoids really useful for the treatment of acute pancreatitis? Shimosegawa, Tooru // Journal of Gastroenterology;2002, Vol. 37 Issue 7, p580
Editorial. Comments on the issue regarding the effectiveness of glucocorticoids for the treatment of acute pancreatitis. Benefit of corticosteroids in human pancreatitis; Role of corticosteroids in the treatment of acute pancreatitis; Details of the important event related to the pathogenesis...
- Pemphigus vulgaris during pregnancy -- a case report. Ali, Habiba Sharaf // Journal of Pakistan Association of Dermatologists;Oct-Dec2011, Vol. 21 Issue 4, p301
Pemphigus vulgaris (PV) is an uncommon immune-mediated bullous dermatosis which is very rare during pregnancy. Its management during pregnancy is a challenge and sometimes very difficult. Only few cases have been reported in literature so far. The disease may be associated with adverse fetal...